Global Whole Genome And Exome Sequencing Market
Healthcare Services

Global Whole Genome And Exome Sequencing Market Key Insights 2024-2033

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

According to The Business Research Company’s Whole Genome And Exome Sequencing Global Market Report 2024, the template market is expected to show promising growth in the forecast period.

The whole genome and exome sequencing market has witnessed exponential growth, driven by significant factors in both historic and forecast periods:

  • Historic Growth: Market size grew from $1.61 billion in 2023 to $2.02 billion in 2024, with a CAGR of 25.5%. Key drivers included:
    • Decreasing sequencing costs
    • Rise in genetic disorders
    • Clinical applications
    • Advancements in bioinformatics
    • Expansion of genomic data repositories
  • Forecast Growth: Expected to reach $4.91 billion by 2028, growing at a CAGR of 24.8%. Factors contributing to growth include:
    • Population genomics initiatives
    • Demand for precision medicine
    • Advancements in single-cell sequencing
    • Expansion of non-invasive prenatal testing (NIPT)
    • Application in rare disease research

View More On The Whole Genome And Exome Sequencing Market Report 2024 –

The Role of Personalized Medicine in Market Expansion

The surge in demand for personalized medicine is a key growth driver for the whole genome and exome sequencing market:

  • Personalized Medicine: Tailors healthcare interventions based on individual genetics, environment, and lifestyle.
  • Market Impact: Over 75,000 genetic testing products and 300 personalized medicines expected by 2022.
  • FDA Approvals: Significant portion of new molecular entities (NMEs) classified as personalized, driving market growth.

Leading Companies Shaping the Market

Major players driving innovation and market expansion include:

  • Siemens AG
  • Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific Inc.
  • Cytiva (Danaher Corporation)
  • Illumina Inc.
  • Agilent Technologies Inc.
  • Eurofins Scientific SE
  • Canon Medical Systems Corporation
  • Bio-Rad Laboratories Inc.

Technological Innovations Driving Market Competitiveness

Innovations such as ultra-fast NGS solutions are transforming the landscape of whole genome and exome sequencing:

  • Ultra-Fast NGS: QIAGEN launched a platform processing whole genomes in 25 minutes for $1 in cloud computing costs, enhancing efficiency and scalability.
  • Market Significance: Accelerates genomic data analysis, facilitating rapid decision-making and adoption of personalized medicine.

Strategic Acquisitions and Market Influence

Strategic moves by industry leaders, like QIAGEN’s acquisition of Verogen, strengthen market capabilities:

  • QIAGEN’s Acquisition: Enhances capabilities in human ID and forensics, bolstering leadership in NGS tools and services.
  • Market Impact: Broadens solution offerings, potentially influencing market dynamics and competitiveness.

Market Segmentation

The whole genome and exome sequencing market is segmented by:

  1. Product Type: Kits, Instruments
  2. Workflow: Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES)
  3. Applications: Diagnostics, Cancer, Monogenic Disorders, Diabetes, Drug Discovery and Development, Personalized Medicine, Agriculture and Animal Research, Other Applications
  4. End-User: Research Centers, Academic and Government Institutions, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, Other End Users

Regional Insights

  • North America: Largest market in 2023, driven by technological advancements and healthcare infrastructure.
  • Asia-Pacific: Fastest-growing region, expected to witness significant expansion due to rising healthcare investments and genetic research initiatives.


The whole genome and exome sequencing market is poised for exponential growth, fueled by advancements in technology, rising demand for personalized medicine, and strategic industry initiatives. With innovations in sequencing technologies and expanding applications across diverse sectors, the market is set to play a pivotal role in healthcare advancements globally. As regions like Asia-Pacific emerge as key growth centers, the landscape of genomic research and personalized healthcare is expected to evolve rapidly, offering new opportunities for market players and stakeholders alike.

Request A Sample Of The Global Whole Genome And Exome Sequencing Market Report 2024: